`Patent No. 7,919,499
`Petition for Inter Partes Review
`Attorney Docket No. AMNEAL 7.1R-005
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`AMNEAL PHARMACEUTICALS LLC,
`Petitioner,
`
`v.
`
`ALKERMES PHARMA IRELAND LIMITED,
`
`Patent Owner.
`
`Patent No. 7,919,499 to Elliot Ehrich
`Issue Date: May 19, 2015
`Title: NAL TREXONE LONG ACTING
`FORMULATIONS AND METHODS OF USE
`
`Inter Partes Review No. IPR20 18-00943
`
`PETITIONER'S POWER OF ATTORNEY
`
`Mail Stop: Patent Board
`Patent Trial and Appeal Board
`U.S. Patent And Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`5388829 _ l .docx
`
`
`
`PETITIONER'S POWER OF ATTORNEY
`
`I hereby appoint Practitioners associated with the firm of Lerner, David,
`
`Littenberg, Krumholz & Mentlik, LLP, 600 South Avenue West, Westfield,
`
`New Jersey 07090 (Customer Number 00530) as Petitioner's attorneys
`
`to
`
`prosecute the above-captioned Inter Partes Review proceeding, and to transact all
`
`business in the United States Patent and Trademark Office connected therewith,
`
`including the appointment of lead and backup counsel. Please recognize the
`
`correspondence address for that Customer Number (including any electronic mail
`
`address) for the above-captioned Inter Partes Review, filed herewith, to be the
`
`address associated with the appointed lead and backup counsel.
`
`AMNEAL PHARMACEUTICALS LLC
`
`Dated: t1ft! ) 20 1 Z() I 8
`
`Ken M. Zeidner
`Vice President - Global Intellectual
`Property Portfolio and Strategy
`
`5388829 _ l .docx
`
`